Carbon Monoxide: Foe . . . . or friend? Leo Otterbein on the potential of carbon monoxide in medicine
Science FareShow Notes
Our guest today is Dr. Leo Otterbein, a professor of surgery at Beth Israel Deaconess Medical Center and Harvard Medical School. Leo’s research group focuses on the role of carbon monoxide as a therapeutic agent in medical applications ranging from organ transplant to infection to cancer. Inhaled carbon monoxide is currently in numerous FDA trials based in large part due the research in Leo's lab over the past decade. Leo is also chair of the Beth Israel Deaconess Medical Center (BIDMC) Institutional Animal Care and Use Committee. As the site miner for the BIDMC Center for the Integration of Medicine and Innovative Technology and member of the Boston Biomedical Innovations Center Technology Assessment and Development Group, Leo mentors and provides specialized expertise in entrepreneurial start-up ventures for innovative technologies. Leo trains graduate students, post-doctoral fellows, surgical residents, and junior faculty in basic research, grant proposals and career guidance.
On the episode, we talk about the myriad possibilities of carbon monoxide (yes, carbon monoxide!) in medicine, ranging from its use in organ transplantation, cancer, wound care, and sickle cell anemia. Hosted on Acast. See acast.com/privacy for more information.
More from Science Fare
In this mini episode, Dr. Jonathan Bogan explains how insulin triggers the TUG protein to help move GLUT 4 transporter proteins from inside the cell to the cell membrane. There, they transport glucose from the bloodstream into the cell using facilitated diffusion. Tune in next week for the full-length interview. Hosted on Acast. See acast.com/privacy for more information.
Dr. Dina Simkin is an Research Assistant Professor at Northwestern University's Feinberg School of Medicine whose research mainly focuses on how on how mutations in ion channel proteins contribute to pediatric epilepsy and neurodevelopmental disorders. Dr. Simkin earned her BS in Biochemistry, and then proceeded to earn PhDs in Neuroscience, Biophysics, and in Cellular and Molecular Pharmacology. She additionally completed post-graduate training in both the neurophysiology of aging and stem cell-derived neuronal models of epileptic channelopathy.
In this mini episode, Dr. Dina Simkin tells us how she uses CRISPR to do more elegant experiments for her work on ion channels. Tune in next week for the full-length interview. Hosted on Acast. See acast.com/privacy for more information.
Lydia Pecker, M.D., is a pediatric hematologist and director of research and advocacy at the Sickle Cell Center for Adults at Johns Hopkins University. She previously served as the founding director of the Center's Young Adult Clinic, which was built to support young people transitioning from pediatric to adult care systems. She received her undergraduate degree in Africana studies from Brown University, earned her M.D. at the University of Pennsylvania School of Medicine, and received a Master's degree in Health Sciences from the Bloomberg School of Public Health.
In this mini episode, Dr. Lydia Pecker explains the complexity in real-life sickle cell inheritance patterns. Tune in next week for the full-length interview. Hosted on Acast. See acast.com/privacy for more information.